About Triangle Pharmaceuticals
Triangle Pharmaceuticals is a company based in Staten Island (United States) founded in 1994 was acquired by Alcami in January 2020.. Triangle Pharmaceuticals has raised $135.2 million across 4 funding rounds from investors including Gilead, Abbott and Alcami. Triangle Pharmaceuticals offers products and services including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage. Triangle Pharmaceuticals operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Staten Island, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alcami Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Triangle Pharmaceuticals
Triangle Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers sterile and oral solid dose production for pharmaceuticals.
Provides testing and method development for pharma and biologics.
Delivers secure cGMP storage with calibration and validation.
Funding Insights of Triangle Pharmaceuticals
Triangle Pharmaceuticals has successfully raised a total of $135.2M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $58.2 million completed in March 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Private Equity Round — $58.2M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2001 | Amount | Private Equity Round - Triangle Pharmaceuticals | Valuation |
investors |
|
| Dec, 1998 | Amount | Private Equity Round - Triangle Pharmaceuticals | Valuation |
investors |
|
| Jun, 1997 | Amount | Private Equity Round - Triangle Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Triangle Pharmaceuticals
Triangle Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gilead, Abbott and Alcami. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Developer of medical devices, generic pharmaceuticals, and nutrition products
|
Founded Year | Domain | Location | |
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Triangle Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Triangle Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Triangle Pharmaceuticals Comparisons
Competitors of Triangle Pharmaceuticals
Triangle Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Triangle Pharmaceuticals
Frequently Asked Questions about Triangle Pharmaceuticals
When was Triangle Pharmaceuticals founded?
Triangle Pharmaceuticals was founded in 1994 and raised its 1st funding round 1 year after it was founded.
Where is Triangle Pharmaceuticals located?
Triangle Pharmaceuticals is headquartered in Staten Island, United States. It is registered at Staten Island, New York, United States.
Is Triangle Pharmaceuticals a funded company?
Triangle Pharmaceuticals is a funded company, having raised a total of $135.2M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $29M, raised on Jun 01, 1995.
What does Triangle Pharmaceuticals do?
Triangle Pharmaceuticals was a specialty pharmaceutical company was developing antiviral drug candidates with a particular focus on therapies for the HIV and the hepatitis B virus. Its lead product Coviracil, a nucleoside reverse transcriptase inhibitor was in Phase 3 trials for the treatment of HIV. It was also developing Amdoxovir, a guanosine nucleoside analog for HIV and Clevudine, a pyrimidine nucleoside analog for chronic Hepatitis B. In December 2002, Gilead acquired Triangle Pharmaceuticals for 464M.
Who are the top competitors of Triangle Pharmaceuticals?
Triangle Pharmaceuticals's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
What products or services does Triangle Pharmaceuticals offer?
Triangle Pharmaceuticals offers Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.